VRB-101 for Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to identify the weekly oral dose of VRB-101 (oral ecnoglutide) that can effectively maintain body weight in participants with a history of obesity or overweight with weight-related comorbidities.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive weekly oral doses of VRB-101 or placebo for weight maintenance
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Ecnoglutide (VRB-101)
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Placebo Group
Participants will receive VRB-101 once every week.
Participants will receive VRB-101 once every week.
Participants will receive VRB-101 once every week.
Participants will receive matching placebo to VRB-101 once every week.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Verdiva Bio Dev Limited
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.